Elisa M. Piella

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 07, 2026

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Journal: Cephalalgia : an international journal of headache

Published: February 13, 2026

Role of the Clock Drawing Test in Differential Diagnosis of Alzheimer's Disease: Clinical Findings in Relation to CSF Biomarkers.

Role of the Clock Drawing Test in Differential Diagnosis of Alzheimer's Disease: Clinical Findings in Relation to CSF Biomarkers.

Journal: International journal of molecular sciences

Published: January 22, 2026

Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).

Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).

Journal: Frontiers in neurology

Published: January 09, 2026

Plasma p-tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach.

Plasma p-tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: November 20, 2025

Exploring Frailty Status and Blood Biomarkers: A Multidimensional Approach to Alzheimer's Diagnosis.

Exploring Frailty Status and Blood Biomarkers: A Multidimensional Approach to Alzheimer's Diagnosis.

Journal: Geriatrics (Basel, Switzerland)

Published: July 14, 2025

Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.

Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.

Journal: Journal of Alzheimer's disease : JAD

Published: January 27, 2025

Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications.

Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications.

Journal: International journal of molecular sciences

Published: October 01, 2024

Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study).

Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study).

Journal: The journal of headache and pain

Published: September 20, 2024

Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression.

Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression.

Journal: Sensors (Basel, Switzerland)

Published: August 09, 2024

Correction to: Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG‑PET presentation in spinocerebellar ataxia 17: a case report.

Correction to: Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG‑PET presentation in spinocerebellar ataxia 17: a case report.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 28, 2024

The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting.

The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting.

Journal: Scientific reports

Published: January 31, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026